The Utility of the Myriad myRisk Hereditary Cancer Test
Elizabeth Garner, MD, MPH, vice president, Clinical Affairs, Preventive Care, Myriad Genetics, discusses the Myriad myRisk Hereditary Cancer Test.
Clinical Pearls
Elizabeth Garner, MD, MPH, vice president, Clinical Affairs, Preventive Care, Myriad Genetics, discusses the Myriad myRisk Hereditary CancerTMTest.
- MyRisk is a genetic test that looks for mutations in 25 genes that are known to be associated with significantly elevated risk for cancer
- There are eight major cancers the test can detect, including breast cancer, ovarian cancer, melanoma, and endometrial cancer.
- The test allows physicians to increase the rate of detection for individuals that have mutations or who have hereditary cancer syndromes
Related Videos
Related Content
Sequencing Sacituzumab and Other Drugs in HR+, HER2- Breast Cancer
May 16th 2024Article
During a Case-Based Roundtable® event, Stephanie L. Graff, MD, discussed multiple later-line treatment options in hormone receptor–positive breast cancer with participants in the first article of a 2-part series.
Read More
